Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

STRYKER CORPORATION

(SYK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Stryker Restructures Operations Into Two Business Segments

01/14/2022 | 01:26pm EST

By Kimberly Chin


Stryker Corp. said it will separate its operations into two reportable business units instead of three to help align the company under a new internal reporting structure.

The medical-technology company said its business will now operate under a MedSurg and neurotechnology segment and an orthopaedics and spine segment. The company previously had three reportable business units: one dedicated to orthopaedics, another to MedSurg and a third to neurotechnology and spine.

The company said the restructuring follows the transition of responsibilities of its president and chief operating officer, Timothy Scannell. Last year, Stryker said Mr. Scannell intended to retire at the end of March 2023. The company said he would move to an advisory role, effective Oct. 1, 2021, and his duties would be divided between group Presidents J. Andrew Pierce and Spencer Stiles.

Mr. Pierce will help run the MedSurg and neurotechnology business and Mr. Stiles will help run the orthopaedics and spine segment, Stryker said in a securities filing.

In the third quarter, orthopaedic net sales netted $1.5 billion, a 16% increase from the previous year. MedSurg net sales were $1.8 billion, representing a 9.4% increase over last year. The neurotechnology and spine segment had net sales of around $900 million, up 7.3% year over year.

Stryker's shares fell 2% on Friday to $262.44.


Write to Kimberly Chin at kimberly.chin@wsj.com


(END) Dow Jones Newswires

01-14-22 1326ET

Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION -6.38% 59.01 Delayed Quote.-13.12%
STRYKER CORPORATION -0.84% 258.3 Delayed Quote.-3.41%
All news about STRYKER CORPORATION
01/14Stryker Restructures Operations Into Two Business Segments
DJ
01/14STRYKER : Supplemental Product Sales Information - Form 8-K
PU
01/14STRYKER CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
01/11STRYKER CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibi..
AQ
01/10NORTH AMERICAN MORNING BRIEFING : Yields Rise, -3-
DJ
01/07Stryker's Offer for Vocera Looks 'Rich' But Deal Rationale 'Justified,' RBC Says
MT
01/07Stryker's $3 Billion Vocera Deal Represents 'Rich' Valuation, But Strategic Rationale J..
MT
01/07Today on Wall Street: Is it legit?
01/07Morgan Stanley Downgrades Stryker to Equalweight From Overweight; Price Target is $305
MT
01/07ANALYST RECOMMANDATIONS : AT&T, BP Plc, Costco, Lyft, Starbucks...
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Financials (USD)
Sales 2021 17 055 M - -
Net income 2021 2 146 M - -
Net Debt 2021 9 264 M - -
P/E ratio 2021 44,7x
Yield 2021 0,98%
Capitalization 97 441 M 97 441 M -
EV / Sales 2021 6,26x
EV / Sales 2022 5,73x
Nbr of Employees 43 000
Free-Float -
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Last Close Price 258,30 $
Average target price 286,59 $
Spread / Average Target 11,0%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Timothy J. Scannell Executive Advisor
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Sector and Competitors